
Gregory E Holt MD PhD
Critical Care Medicine, Interventional Pulmonology, Pleural Disease, Thoracic Oncology
Associate Professor, Medicine, University of Miami Leonard M. Miller School of Medicine
Join to View Full Profile
1600 NW 10th AveMiami, FL 33136
Phone+1 305-689-9561
Fax+1 305-243-6992
Dr. Holt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Gregory Holt, MD, is a pulmonologist located in Miami, FL, with subspecialties in Critical Care Medicine, Interventional Pulmonology, Pleural Disease, and Thoracic Oncology. He completed his medical education at Loyola University Chicago Stritch School of Medicine and his residency in Internal Medicine at MedStar Health Georgetown University/Georgetown Hospital. He furthered his expertise with a fellowship at the University of Washington. His clinical experience includes advanced cardiac life support and respiratory failure. Dr. Holt has contributed to several publications, focusing on topics such as COVID-19 immunometabolism and lung cancer screening, which have been cited by other researchers. He has received CMS Meaningful Use certifications for various Epic Systems modules from 2013 to 2016.
Education & Training
University of WashingtonFellowship, Pulmonary Disease and Critical Care Medicine, 2006 - 2009
MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 2002 - 2006
Loyola University Chicago Stritch School of MedicineClass of 2002
Certifications & Licensure
FL State Medical License 2011 - 2027
WA State Medical License 2006 - 2011
VA State Medical License 2002 - 2006
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013, 2015-2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013, 2015-2016
Clinical Trials
- Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 Start of enrollment: 2020 Dec 02
- Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier Start of enrollment: 2022 Jul 18
- Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy Start of enrollment: 2017 Apr 13
Publications & Presentations
PubMed
- Pilot trial of delayed versus immediate financial incentives for smoking cessation.Sneha Sathya, Catherine Zaw, Jalima Quintero, Lisa Hue, Fei Tang
Contemporary Clinical Trials Communications. 2026-04-01 - 3 citationsMetabolomics and Cytokine Signatures in COVID-19: Uncovering Immunometabolism in Pathogenesis.Mohammad Mehdi Banoei, Abdulrazagh Hashemi Shahraki, Kayo Santos, Gregory Holt, Mehdi Mirsaeidi
Metabolites. 2025-09-11 - 6 citationsInvestigating Metabolic Phenotypes for Sarcoidosis Diagnosis and Exploring Immunometabolic Profiles to Unravel Disease Mechanisms.Mohammad Mehdi Banoei, Abdulrazagh Hashemi Shahraki, Kayo Santos, Gregory Holt, Mehdi Mirsaeidi
Metabolites. 2024-12-31
Press Mentions
Lung Precision Oncology Program (LPOP)October 3rd, 2024
Miller School Study Evaluates Predictive Value of Sequential Organ Failure Assessment Score Across Patient PopulationsNovember 19th, 2021
It’s Not Just a Simple Doctor’s Visit When the Patient Is a GorillaDecember 11th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









